Article Versions Notes

Li Y, Inam M, Hasan MW, Chen K, Zhang Z, Zhu Y, Huang J, Wu Z, Chen W, Li M. Optimizing Antitumor Effect of Triple-Negative Breast Cancer via Rosmarinic Acid–β-Cyclodextrin Inclusion Complex. Pharmaceutics. 2024; 16(11):1408. https://doi.org/10.3390/pharmaceutics16111408

Li, Yuan, Muhammad Inam, Muhammad Waqqas Hasan, Kaixin Chen, Zhongqian Zhang, Yongcheng Zhu, Jiayu Huang, Zhuowen Wu, Wenjie Chen, and Min Li. 2024. "Optimizing Antitumor Effect of Triple-Negative Breast Cancer via Rosmarinic Acid–β-Cyclodextrin Inclusion Complex" Pharmaceutics 16, no. 11: 1408. https://doi.org/10.3390/pharmaceutics16111408

Li, Y., Inam, M., Hasan, M. W., Chen, K., Zhang, Z., Zhu, Y., Huang, J., Wu, Z., Chen, W., & Li, M. (2024). Optimizing Antitumor Effect of Triple-Negative Breast Cancer via Rosmarinic Acid–β-Cyclodextrin Inclusion Complex. Pharmaceutics, 16(11), 1408. https://doi.org/10.3390/pharmaceutics16111408